CMO Moves: Regulatory catalysts for therapy manufacturing -January
Pharmaceutical Technology
JANUARY 15, 2023
The UK’s National Institute for Health and Care Excellence (NICE) conducts health technology assessments (HTAs) based on a cost-effectiveness analysis for the given use of a therapy in a specific setting. Esteve Pharmaceuticals SA, Evonik Industries AG, Uquifa SA, and Yuhan Chemical Inc are manufacturing the small molecule API.
52 
Let's personalize your content